Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Richard D. O'Connor"'
Autor:
Richard D O'Connor
Publikováno v:
Patient Related Outcome Measures, Vol 2011, Iss default, Pp 41-55 (2011)
Richard D O'ConnorSharp Rees-Stealy Medical Group, San Diego, CA, USAAbstract: In the United States, budesonide/formoterol pressurized metered-dose inhaler (pMDI) is approved for treatment of asthma in patients aged ≥12 years whose asthma is not ad
Externí odkaz:
https://doaj.org/article/900805154485482f883968a192009b53
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 21:1014-1019
Asthma medication ratio (AMR) ≥ 0.5 has been shown to predict asthma exacerbations. This study explores the impact of increasing or decreasing inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) use over a 7-year period on achieving an AMR o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546f9f11ab697d107405107a83a28da4
https://doi.org/10.18553/jmcp.2015.21.11.1014
https://doi.org/10.18553/jmcp.2015.21.11.1014
Autor:
Richard D. O'Connor
Publikováno v:
Journal of the Southwest. 56:687-719
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea104638dede1c7de3cec0d2ad50a37
https://doi.org/10.1353/jsw.2014.0025
https://doi.org/10.1353/jsw.2014.0025
Autor:
Walter P. Parks, Richard D. O'Connor
Publikováno v:
Journal of the Southwest. 54:9-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa6776f3f0cf87a46edb99326afb8a20
https://doi.org/10.1353/jsw.2012.0012
https://doi.org/10.1353/jsw.2012.0012
Autor:
Richard D. O'Connor
Publikováno v:
Journal of the Southwest. 54:59-70
The village that we know today as Juan Mata Ortiz came into existence under very different circumstances. The brilliant American electrical engineer and entrepreneur Fred Stark Pearson established the Mexico Transportation Company, Ltd., in Canada on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a358b90ec6170f8358f317504b9a0534
https://doi.org/10.1353/jsw.2012.0002
https://doi.org/10.1353/jsw.2012.0002
Autor:
Aidan A. Long, Stephen P. Peters, Eugene R. Bleecker, David Klingman, Benjamin Gutierrez, Richard D. O'Connor, Donald P. Tashkin
Publikováno v:
Journal of Asthma. 47:422-428
Monitoring indicators of subacute lack of asthma control (SALAC) may help to reduce asthma morbidity.To determine whether SALAC, independent of current asthma exacerbations, is associated with subsequent acute asthma exacerbations.Administrative clai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c24f9f4f86bc7d79679c6ab76366b2c
https://doi.org/10.3109/02770901003605332
https://doi.org/10.3109/02770901003605332
Publikováno v:
Journal of Asthma. 47:217-223
Assessment of patient-reported outcomes is important in evaluating the impact of asthma treatment. This study was conducted to compare effects of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler with fixed-dose flutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edc99b4f68125ae9d5a67887eae3e6a0
https://doi.org/10.3109/02770900903497154
https://doi.org/10.3109/02770900903497154
Autor:
Ellyn Hartman, Richard D. O'Connor
Publikováno v:
The Journal for Nurse Practitioners. 5:284-293
Asthma, the most common chronic disease in children, is characterized by chronic inflammation of the respiratory system. If left uncontrolled, persistent asthma can have serious negative clinical outcomes. Thus, the earliest possible diagnosis based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff7eea0bef3dc0d932f8ec3320b7cceb
https://doi.org/10.1016/j.nurpra.2008.09.007
https://doi.org/10.1016/j.nurpra.2008.09.007
Publikováno v:
Annals of Allergy, Asthma & Immunology. 97:236-243
The burden of asthma is substantial, and the overall cost of its management is growing.To compare asthma-related charges and resource utilization across disease severity levels in the year after initial asthma treatment with any inhaled corticosteroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffd3aa38811b7fa6c875ca2076fc042
https://doi.org/10.1016/s1081-1206(10)60020-8
https://doi.org/10.1016/s1081-1206(10)60020-8
Autor:
Antonio P. Legorreta, Priti Jhingran, Ranjani Manjunath, Amanda Gilmore, Richard D. O'Connor, Richard H. Stanford
Publikováno v:
Current Medical Research and Opinion. 22:453-461
Clinical trials have demonstrated improved efficacy of fluticasone propionate/salmeterol (100/50 mcg) in a single device (FSC) compared with montelukast (10 mg) (MON). This study was designed to assess asthma control, asthma-related quality of life,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5074359263873634131e10b5c01a8a5
https://doi.org/10.1185/030079906x89793
https://doi.org/10.1185/030079906x89793